Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

Clinical trial NCT07366528 · RECRUITING

Trial details

NCT number: NCT07366528
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Cancer (GC)Adjuvant Chemotherapy Stage 3 Cancer Docetaxel Oxaliplatin

Start date: 2025-12-15
Primary completion: 2028-10-30
Enrollment: 387

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.